Revna Biosciences Raised Capital to Scale Precision Medicine

🧬 Meet RevnaBio

• Ghana-based Revna Biosciences is a precision medicine company. They specialize in advanced molecular diagnostics and clinical research.

• They just closed an investment round for an undisclosed amount.

• Investor check. Local fund Mirepa Capital injects growth capital.

---

🏥 Filling the Gap

• Right now, many patients in Africa can't get high-end molecular testing for cancer or infectious diseases nearby. Doctors often have to ship samples overseas. This is slow and expensive.

• RevnaBio’s local testing lets doctors provide personalized treatments right in Ghana. No international shipping required.

---

🔬 World-Class Tech

• They run a biomedical facility in Accra. It’s built to international standards for genomic testing.

• The lab is already licensed by FDA-Ghana and the Health Facilities Regulatory Agency.

• The team won over investors by combining deep local knowledge with a model that makes advanced diagnostics more accessible.

---

🌍 Scaling Up

• Management is using the new capital to bring their diagnostic tools to more people across West Africa.

• They’re also putting money into therapeutic research.